Impact of mitral intervention on outcomes of patients with mitral valve dysfunction and annulus calcification

Nahoko Kato1, Patricia A Pellikka1, Christopher G Scott2

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Insights

Mitral intervention for severe mitral valve dysfunction in patients with mitral annulus calcification significantly reduces all-cause mortality. Early intervention improves survival rates in this high-risk population.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Echocardiography

Background:

  • Mitral annulus calcification (MAC) presents significant surgical risks due to patient age, comorbidities, and calcification challenges.
  • The clinical impact of mitral intervention in patients with MAC and severe mitral valve dysfunction (MVD) remains unclear.

Purpose of the Study:

  • To compare all-cause mortality between patients with MAC and severe MVD who underwent mitral intervention versus those who did not.
  • To evaluate the effectiveness of early mitral intervention in this patient cohort.

Main Methods:

  • Retrospective analysis of 357 patients with MAC and severe MVD identified via transthoracic echocardiography.
  • Stratification into two groups: early mitral intervention (<1 year post-TTE) versus no or later intervention.
  • Primary endpoint was all-cause mortality, with survival analysis and adjusted hazard ratios.

Main Results:

  • 108 patients underwent early mitral intervention; they were younger and had fewer comorbidities than the no-intervention group.
  • The intervention group demonstrated significantly higher estimated survival rates at 1 and 4 years (80% vs. 72% and 55% vs. 35%, respectively).
  • Mitral intervention was an independent predictor of lower mortality (HR=0.66, p=0.046) after adjusting for key clinical factors.

Conclusions:

  • Early mitral intervention in patients with MAC and severe MVD is associated with reduced all-cause mortality.
  • Mitral intervention is an independent protective factor against mortality in this high-risk population.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
36
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
72
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
46
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
56
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
42
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
62